Article thumbnail

The CEACAM1 expression is decreased in the liver of severely obese patients with or without diabetes

By Wonae Lee
Topics: Research
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3104481
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2008). al: Carcinoembryonic antigen-related cell adhesion molecule 1: a link between insulin and lipid metabolism. Diabetes
  2. (2005). al: Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology
  3. (1997). CEA adhesion molecules: multifunctional proteins with signalregulatory properties.
  4. (2009). Chemotactic cytokines, obesity and type 2 diabetes: in vivo and in vitro evidence for a possible causal correlation? Proc Nutr Soc
  5. (1988). DE: Hepatic metabolism of insulin.
  6. (2004). Dysfunctional fat cells, lipotoxicity and type 2 diabetes.
  7. (1997). Dysregulation of carcinoembryonic antigen group members CGM2, CD66a (biliary glycoprotein), and nonspecific cross-reacting antigen in colorectal carcinomas. Comparative analysis by northern blot and in situ hybridization.
  8. (2005). et al: Insulin acutely decreases hepatic fatty acid synthase activity. Cell Metab
  9. (2004). et al: Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice.
  10. (2006). et al: Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes
  11. (2006). Feve B: Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw
  12. (1998). FG: Insulin degradation: progress and potential. Endocr Rev
  13. GI: Lipid-induced insulin resistance: unravelling the mechanism.
  14. (2005). Hatakeyama K: Loss of carcinoembryonic antigen-related cell adhesion molecule 1 expression is an adverse prognostic factor in hepatocellular carcinoma. Cancer
  15. (1991). Hixson DC: Detection of cell-CAM 105 in the pericanalicular domain of the rat hepatocyte plasma membrane. Hepatology
  16. (1988). Insulin degradation: mechanisms, products, and significance. Endocr Rev
  17. Insulin resistance, as expressed by HOMA-R, is strongly determined by waist circumference or body mass index among Japanese working
  18. (1989). Kamarck ME: Carcinoembryonic antigens: alternative splicing accounts for the multiple mRNAs that code for novel members of the carcinoembryonic antigen family.
  19. (1995). Lanckmans S: Liver disturbances in obesity and diabetes mellitus.
  20. (2002). Luyckx FH: Obesity and liver disease. Best Pract Res Clin Endocrinol Metab
  21. (2000). Non-esterified fatty acids and the liver: why is insulin secreted into the portal vein? Diabetologia
  22. (2000). Pathogenesis of type 2 diabetes: the relative contribution of insulin resistance and impaired insulin secretion.
  23. (2006). RS: CEACAM1: contact-dependent control of immunity. Nat Rev Immunol
  24. (1995). SI: Insulin-stimulated phosphorylation of recombinant pp120/HA4, an endogenous substrate of the insulin receptor tyrosine kinase. Biochemistry
  25. (2003). The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol Metab
  26. (2001). The CEACAM1-L Ser503 residue is crucial for inhibition of colon cancer cell tumorigenicity. Oncogene
  27. The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes.
  28. (2006). Utzschneider KM: Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature